News




Events

Oct 17, 2016 - Oct 17, 2016

EAPB General Meeting

Sep 27, 2016 - Sep 28, 2016

European Business Development Conference 2016

Feb 26, 2014 - Feb 27, 2014

Science to Market 2014

Mar 05, 2013 - Mar 06, 2013

Science to Market 2013

>> Activities
>> Archive

Programme

In order to see the presentations of the speakers, please click on the respective title.
The presentations are not for further distribution; copyright lies with the speakers.

Monday, 7 March 2016

09:00 - 10:00

Registration

10:00 - 10:10

Welcome, Introduction & Opening remarks
Wieland W. Wolf, President of the EAPB

 

Session: Market Trends (Moderator Wieland Wolf)

10:10 - 10:40

"Commercial Deal Structures and Recent Trends"
Christi Mitchell, Highbury Ltd, Hitchin, UK

10:40 - 11:10

"Personalized medicine – are there also approaches outside Oncology"?
Jochen Maas, Sanofi-Aventis Deutschland GmbH, Frankfurt

11:10 - 11.40

"Accelerating Innovation through collaboration"
Cord Dohrmann
, Evotec AG, Hamburg

11:40 - 12:10

Panel Discussion

 

Technology Slam Session 1 (Moderator Marion Michaelis-Kronabel)

12:10 - 12:25

„From Science to Market – legal obstacles to product success”
Christian Lindemann, VOELKER & Partner
Rechtsanwälte Wirtschaftsprüfer Steuerberater mbB, Reutlingen

12:25 - 12:40

“Patenting Biotech Inventions in the U.S. post Myriad and Mayo”
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte | PartG mbB, München

12:40 - 13:00

 Poster Slam

13:00 - 14:00

Lunch Break

 

Session: Regulatory (moderator Jürgen Hess)

14:00 - 14:30

"Medicines, medical devices and other healthcare products – differing regulatory systems"
Jürgen Hess, Pharma Scientific Services Team (P.SS.T), München

14:30 - 15:00

“Challenges in the demarcation of material medical devices from medicinal products. Differences between legal and scientific assessment“
Peter von Czettritz, Preu Bohlig & Partner, München

15:00 - 15:30

"Towards greater Data Transparency – Trends and Impact on Market Access in Europe"
Alexander Natz, EUCOPE, Brüssels, Belgium

15:30 - 16:00

"Current and upcoming regulatory requirements for In-vitro Diagnostics in EU"
Dieter Schönwald, TÜV-Süd Product Service GmbH, München

16:00 - 16:30

Panel Discussion

16:30 - 17:00

Coffee Break

17:00 - 18:30

Technology Slam Session 2 (Moderator Willi Meier)

18:30 - 18:45

Closing Remarks
Wieland W. Wolf, President of the EAPB

 18:45

Come Together at DECHEMA Haus

 

Tuesday, 8 March 2016

09:00 - 09:10

Opening
Wieland W. Wolf, President of the EAPB

 

Session: Big Data (Moderator Holger Bengs)

09:10 - 09:40

“Big Data in Human Genetics: Challenges and Chances for disruptive Business Models”
Daniela Steinberger, bio.logis Group, Frankfurt

09:40 - 10:10

 "Digital Medicine: from the App to Big Data"
Claus Kusnierz-Glaz, PriceWaterhouseCoopers, Frankfurt

10:10 - 10:40

Coffee Break

 

Session: Big Data (continued)

10:40 - 11:10

"Genetalk- an approach to end the diagnostic odyssey for patients with rare genetic disorders"
Peter Krawitz, Universiteitsklinikum Charité Berlin

11:10 - 11:40

"Big Data: Big Business - Big Failures?"
Martin Pöhlchen, Sinfonie Life Science Management GmbH, Planegg

11:40 - 12:10

Panel Discussion

12:10 - 12:45

Technology Slam Session 3 (Moderator Holger Bengs)

12:45 - 13:45

Lunch Break

 

Session: Technology Transfer (Moderator Jürgen Walkenhorst)

13:45 - 14:15

"Science-to-Commercialization - a Max Planck Model for Early Innovative Drug Discovery"
Bert Klebl, LDC Lead Discovery Center, Dortmund

14:15 - 14:45

"The Infinite Value-Inflection Point: Making the Untransactable Transactable"
Iain Thomas, Cambridge Enterprise, Cambridge, UK

14:45 - 15:15

“Hands on Translation: From Infinity to Beyond”
Michael Dalrymple, MRC Technology, London, UK

15:15 - 15:45

Panel Discussion

15:45 - 16:00

EAPB Award

16:00 - 16:15

Closing Remarks
Wieland W. Wolf, President of the EAPB

Programme as of February 2016